【摘要】 早期脑梗死应用东菱克栓酶溶栓 ,因其显效率高 (93%以上 )、无明显副作用、使用方便、疗程短等优点已越来越多地被临床重视和患者接受 .介绍 6 0例脑梗死病人应用东菱克栓酶溶栓治疗的经验、体会、药物的作用机制和使用方法 ,以提高疗效 ,减少药物副作用更多还原

【Abstract】 Cerbralinfaretion treated with Batroxobin in the early stage has such advantages as high effect rate(over 93%),no evident by effect,convenience to use and short course of treatment,etc,which has been more and more accepted by patients.The experience,mechanism and methods of cerebral infarction treated with Batroxobin were introduced to improve the therapy and decrease the by effect of medicine.更多还原